CorMedix (CRMD) Income towards Parent Company (2010 - 2026)

CorMedix has reported Income towards Parent Company for 16 years, with the latest figure at -$11.8 million in Q4 2025.

• Quarterly Income towards Parent Company fell 187.47% year-over-year to -$11.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $139.3 million (up 876.67% YoY) and the FY2025 annual result came in at $137.3 million, up 865.52% from the prior year.
• Income towards Parent Company retreated to -$11.8 million in Q4 2025 per CRMD's latest filing, from $108.5 million in the prior quarter.
• Over five years, Income towards Parent Company peaked at $108.5 million in Q3 2025 and troughed at -$17.3 million in Q1 2021.
• A 5-year average of $201598.9 and a median of -$8.4 million in 2021 frame the typical range for Income towards Parent Company.
• The sharpest annual moves came in 2021 and 2025: Income towards Parent Company tumbled 199.88% in 2021, then soared 4001.2% in 2025.
• Over 5 years, Income towards Parent Company stood at -$9.7 million in 2021, then gained by 15.08% to -$8.2 million in 2022, then slumped by 79.73% to -$14.8 million in 2023, then jumped by 191.26% to $13.5 million in 2024, then sank by 187.47% to -$11.8 million in 2025.
• According to Business Quant data, Income towards Parent Company over the past three periods registered -$11.8 million, $108.5 million, and $21.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.